I'd just like to know how this study advances the prospects of RAC and how does this tie in with our new strategy.
How can we get this drug to market to improve patient outlook and make us all some coin.
ASH2023 - Sheba 2.0, page-77
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.85 |
Change
-0.005(0.27%) |
Mkt cap ! $315.1M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.86 | $1.85 | $26.00K | 14.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3574 | $1.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.89 | 500 | 1 |
View Market Depth
| Last trade - 10.08am 17/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |